Muscarinic receptor binding activity in rat tissues by vibegron and prediction of its receptor occupancy levels in the human bladder-Reference-Cited by-同舟云学术

Muscarinic receptor binding activity in rat tissues by vibegron and prediction of its receptor occupancy levels in the human bladder

Published:2021-09-21 Issue:12 Volume:28 Page:1298-1303
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Yamada Shizuo¹,Chimoto Junko¹,Shiho Mizuki²,Okura Takashi²,Morikawa Kana³,Kagota Satomi³,Shinozuka Kazumasa³

Affiliation:

1. Center for Pharma‐Food Research Graduate School of Pharmaceutical Sciences University of Shizuoka ShizuokaJapan

2. Faculty of Pharma‐Science Teikyo University TokyoJapan

3. Department of Pharmacology II School of Pharmacy and Pharmaceutical Sciences Mukogawa Women’s University Nishinomiya Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14696

Reference30 articles.

1. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society

2. Effect of Bothersome Overactive Bladder Symptoms on Health-related Quality of Life, Anxiety, Depression, and Treatment Seeking in the United States: Results From EpiLUTS

3. Functional and molecular biological evidence for a possible β 3 -adrenoceptor in the human detrusor muscle

4. Evidence for β3‐adrenoceptor subtypes in relaxation of the human urinry bladder detrusor: analysis by molecular biological and pharmacological methods;Takeda M;J. Pharmacol. Exp. Ther.,1999

5. β3-Adrenoceptor agonists for overactive bladder syndrome: Role of translational pharmacology in a repositioning clinical drug development project

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional anticholinergic activity of drugs classified as strong and moderate on the anticholinergic burden scale on bladder and ileum;Basic & Clinical Pharmacology & Toxicology;2024-09

2. Anticholinergic adverse events by polypharmacy and anticholinergic burden score;Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics;2024-07-25

3. Predicting muscarinic receptor occupancy in human bladder mucosa from urinary concentrations of antimuscarinic agents for overactive bladder;Drug Metabolism and Pharmacokinetics;2024-06

4. Re: What Are the Short-term Benefits and Potential Harms of Therapeutic Modalities for the Management of Overactive Bladder Syndrome in Women? A Review of Evidence Under the Auspices of the European Association of Urology, Female Non-neurogenic Lower Urinary Tract Symptoms Guidelines Panel;European Urology;2024-04

5. Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs;Geriatrics & Gerontology International;2023-10-23